Wang Yu
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| Immunotech Biopharm Ltd | 06978 | 23-Aug-19 | 25-Jun-25 | CEO | Dr Wang stated that her resignation was due to disagreements with the Board, citing material violation of the explicit agreement regarding the operation and management authority of the CEO under her employment contract. A director living abroad interfering with operations. Lastly two directors no longer representing shareholder interests due to a change of ownership, and governance failure causing divergence from the Company’s vision. |